« High Blood Pressure Pills Maybe Replaced by Vaccine | Main | Corneas from Sea Cucumbers? Patent Pending »

Nov 6
Abilify FDA Approved for Teens With Schizophrenia

Bristol-Myers Squibb (NYSE:BMY) announced that the U.S Food and Drug Administration has approved its drug Abilify for teens aged 13 - 17 that have been diagnosed with schizophrenia.

Abilify (aripiprazole) is an antipsychotic drug that was first approved by the FDA at the end of 2002 for adults with schizophrenia and since that time Bristol-Myers says that more than 12.5 million US prescriptions for the drug have been written.

Abilify"We are extremely pleased that ABILIFY, the first available dopamine partial agonist, is approved for the treatment of pediatric patients (13 to 17 years of age) suffering from schizophrenia," said Tatsuo Higuchi, President and Representative Director, Otsuka Pharmaceutical Co., Ltd. "ABILIFY® (aripiprazole) offers an effective new option to help treat this serious mental illness."

"Schizophrenia is one of the most complex of all mental health disorders," said Elliott Sigal, M.D., Ph.D., Executive Vice President, Chief Scientific Officer and President, Research and Development, Bristol-Myers Squibb. "We remain committed to providing innovative therapies, such as ABILIFY, to help patients, including adolescents, living with schizophrenia."

Extended approval was based on a six-week, double-blind, randomized, placebo controlled multi-center study involving 302 patients in 13 countries.

[Source: Bristol-Myers Squibb Press Release]


1 Comments/Trackbacks




» FDA Approves Abilify as Add-On for Major Depression from PharmaGazette
Earlier this month the U.S Food and Drug Administration approved Abilify for the treatment of schizophrenia in teens and have now expanded that approval to include patients with major depressive disorder.Approved in 2002 for schizophrenia in adult... [Read More]

submit a trackback

TrackBack URL for this entry:

post a comment

Name, Email Address, and URL are not required fields.





Comment Preview

« High Blood Pressure Pills Maybe Replaced by Vaccine | Main | Corneas from Sea Cucumbers? Patent Pending »

Advertise

Watch the Digital Health Revolution


sponsored ads



subscribe


Prefer Email?
Subscribe below-

Enter your Email:


Powered by FeedBlitz What's this?

Current News

Support This Blog

top blogs

business social media

Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!

BIZZlogos - Add your logo - free link to your site
BIZZphotos - Add photos of your products and people
BIZZprofiles - Submit your profile and build your online visibility
BIZZspotlight - Spotlight your business with free links
BIZZvideos - Videos about businesses, products and business people.
BIZZbites - "Digg" for Business - Submit your articles and posts

Know More Media - Health Care / Pharmaceutical / Fitness

know more media network

View Network Map

Network Feed List (OPML)

Know More Media Network
Feed


we support unitus

PRWeb

Influencer



PharmaGazette is a member of the Know More Media network of business related blogs.

Here are some current headlines from some of our business publications:

ProductivityGoal

CallCenterScript

AdHurl

TheBizofKnowledge

LandingTheDeal

CustomersAreAlways

HealthCareVox

BrainBasedBusiness

TheInsurancePolicy

MarketingBlurb